Earnings Preview — 5191 total
Damora Therapeutics walks into its May 7 earnings report carrying two distinctly uncomfortable facts: a CFO who just stepped down and a short interest that has tripled in six weeks. The headline from Monday — CFO Lori…
BDSX reports Q1 2026 results on May 8 with the stock carrying a 25% monthly loss into the print — yet showing signs of near-term stabilisation. The price action tells a split story. Shares fell sharply through April to…
UTZ heads into its May 6 earnings report with short sellers rapidly unwinding what had been a materially elevated position — yet the analyst community remains firmly on edge. Short interest peaked at roughly 12.8% of…
Viatris heads into its May 7 Q1 earnings report with short sellers quietly adding exposure — even as the stock posts its best month in some time. The most notable positioning shift is in short interest. Bears have…
IAC Inc. heads into its Q1 2026 results today with a wave of upward analyst revisions at its back — and the clearest question is whether the fundamentals can validate the optimism. The analyst case for IAC has…
COMPASS Pathways reports Q1 2026 results on May 7 after a month that has completely re-priced the stock — and the short-side has scrambled to keep up. Options positioning has actually turned more bullish into the…
Adeia heads into its May 6 earnings call with the headline numbers already out — and a leadership bombshell overshadowing a solid beat. Q1 results landed after the close on May 4. Adjusted EPS came in at $0.38, beating…
ORIC Pharmaceuticals enters today's earnings report with nearly 30% of its free float sold short — a meaningful bearish overhang for a clinical-stage biotech that has rallied 8% over the past month. Short sellers are…
The Baldwin Insurance Group heads into Tuesday's earnings report with short sellers more active than they have been in months — and options traders showing their most defensive posture of the year. Short interest has…
urban-gro, Inc. heads into its May 6 earnings print as one of the most expensive stocks to borrow in the market — a signal that the lending dynamics around this micro-cap are more dramatic than the short interest level…
Ocugen heads into its Q1 2026 earnings call today heavily scrutinised by short sellers, with the stock's lending dynamics forming the central narrative for the session. Short interest is the dominant signal here. At…
MIRM enters its May 6 Q1 earnings report with a substantial short position and a stock that just broke sharply higher — a combination that makes Thursday's release genuinely consequential for both sides of the…
A concentrated buyer has loaded up on RPAY shares at depressed prices — and those positions now face their first test as the company reports Q1 2026 earnings on May 8. The most striking feature of the setup is the…
Moderna heads into Wednesday's first-quarter release with analysts freshly raising targets — yet none willing to turn bullish. The most striking feature of the run-up is the breadth and speed of analyst target upgrades…
Sonos heads into its fiscal Q2 earnings report on May 6 with two sharply contrasting signals pulling in opposite directions: a 10% activist stake that has been buying aggressively for months, and a short interest…
GrafTech International reports Q1 results on May 7 having staged a remarkable reversal — the stock is up 39% over the past month, yet short sellers appear to be backing away rather than pressing their bets. The…
HG reports Q1 2026 results today against an uncomfortable backdrop: the stock has fallen nearly 8% over the past week to $30.01, with most of that damage — almost 5% — arriving in a single session on Monday. Options…
Lunai Bioworks reports Q3 2026 results on May 8 with a borrow market that, despite cooling sharply from its March extremes, remains far more expensive than most small-cap biotechs — and a short interest picture that…
Guardant Health heads into its May 7 Q1 2026 earnings print with options positioning flashing the most bullish signal in months — a sharp contrast to how the stock was positioned just two weeks ago. The options market…
LOMA heads into its Q1 2026 results with options sentiment at its most cautious in a year — and the borrow market fully drained. The shift in options positioning is the sharpest signal ahead of today's print. The…
